Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Non-exec linked to CentralNic purchase, LSE make another buyback

(Sharecast News) - On the buying side of the ledger on Monday was CentralNic Group, which disclosed that Kestrel Partners had bought more than 70,000 shares. The company said it was told on 16 June that Kestrel purchased 72,000 shares on behalf of its discretionary client accounts.

Kestrel paid 117.1289p for each share, valuing the transaction at a total of £84,332.808.

CentralNic said its non-executive directory, Max Royde, is a partner of, and has a beneficial interest in Kestrel Partners, and is also a shareholder in the similarly-named Kestrel Opportunities.

Following this transaction, Kestrel Opportunities held, and thus Royde was deemed to have a beneficial interest in, 17,926,535 CentralNic shares, and other clients of Kestrel in which Royde had no beneficial interest held 48,631,125 shares.

On a combined basis, Kestrel indirectly held voting rights over 66,557,660 of the firm's shares, representing 23.48% of its issued share capital.

London Stock Exchange Group was meanwhile once again on the selling side of things, as its post-Refinitiv share buyback continued.

The company said York Holdings II sold back another 9,178 shares on 16 June, in a single transaction on the London Stock Exchange.

It received 8,766.43p for each share, giving the sale a value of £804,582.95.

LSE Group director Martin Brand is also a director of York Holdings II, which is understood to be part of the structure owning the consideration shares paid by the exchange operator when its acquisition of Refinitiv from Thomson Reuters and Blackstone was completed.

At 1254 BST, shares in London Stock Exchange Group were down 0.5% at 8,676p, while those in CentralNic Group were ahead 0.35% at 115.8p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Director dealings: Tracsis director snaps up shares
(Sharecast News) - Tracsis revealed on Wednesday that non-executive director Tracy Sheedy had acquired 950 ordinary shares in the AIM-listed transport software provider.
Director dealings: Admiral director raises stake
(Sharecast News) - Admiral Group revealed on Tuesday that non-executive director Justine Roberts had acquired 1,044 ordinary shares in the FTSE 100-listed insurer.
Director dealings: Creo Medical chairman raises stake
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Director dealings: Rentokil Initial director makes share purchase
(Sharecast News) - Rentokil Initial revealed on Friday that non-executive director Brian Baldwin had acquired 7.5m ordinary shares in the FTSE 100-listed pest control business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.